PharmHouse Pursues Formal Restructuring Joint venture seeks creditor protection while it restructures its business, financial obligations Canopy Rivers to provide up to $7.2 million in interim DIP financing TORONTO,...

Exclusive Interview with Canopy Rivers President and CEO Narbe Alexandrian Over the past year, cannabis-focused venture capital firm Canopy Rivers (TSX: RIV) (OTC: CNPOF) has seen more than 1,500...

TerrAscend Congratulates PharmHouse on Securing its Cannabis Cultivation Licence from Health Canada — TerrAscend Canada has a multi-year supply agreement with PharmHouse for 20% of the flowering space of...

SMITHS FALLS, ON, May 9, 2019 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce today that has signed an...

Canopy Rivers Announces $80 Million Bank Debt Facility at PharmHouse TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) today announced...

Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) — Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV)...

Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) — Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV)...